Due to its essential role in viral replication and its multifunctionality, SARS-CoV-2 Nsp1 is an attractive target for antiviral drugs, and CFS offers a fast and effective method to find starting points for the development of such drugs. The gene discussed is SH2D3A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.